ARTICLE | Distillery Therapeutics
Cancer
October 20, 2016 7:00 AM UTC
Patient sample, cell culture and mouse studies suggest inhibiting SF3B1 could help treat secondary AML in elderly patients. Leukemic stem cells from elderly patients with secondary AML exhibited a dif...
BCIQ Company Profiles
BCIQ Target Profiles